Ligand validation:4IM2

BX7: N-(3-{[5-iodo-4-({3-[(thiophen-2-ylcarbonyl)amino]propyl}amino)pyrimidin-2-yl]amino}phenyl)pyrrolidine-1-carboxamide

BX7 is a Ligand Of Interest in 4IM2 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4IM2_BX7_A_701	36%	7%	0.214	0.91	1.46	3.4	5	15	3	0	100%	0.51
4IW0_BX7_A_701	63%	0%	0.1	0.894	7.21	4.99	23	21	2	0	100%	1
4IWP_BX7_A_701	38%	0%	0.243	0.945	6.44	4.94	22	23	1	0	100%	1
4IM3_BX7_A_701	14%	7%	0.306	0.859	1.31	3.43	3	16	2	0	100%	0.46
6O8B_BX7_A_701	7%	2%	0.385	0.849	4.46	2.18	15	10	3	0	100%	1
4JL9_BX7_A_701	13%	10%	0.294	0.838	2.41	1.88	8	11	0	0	100%	0.9829

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.